Gilead Sciences Inc (GILD)
73.26
-0.43
(-0.58%)
USD |
NASDAQ |
Mar 18, 16:00
73.32
+0.06
(+0.08%)
After-Hours: 20:00
Gilead Sciences Price to Book Value: 3.997 for March 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 18, 2024 | 3.997 |
March 15, 2024 | 4.020 |
March 14, 2024 | 4.049 |
March 13, 2024 | 4.143 |
March 12, 2024 | 4.096 |
March 11, 2024 | 4.110 |
March 08, 2024 | 4.099 |
March 07, 2024 | 4.019 |
March 06, 2024 | 3.963 |
March 05, 2024 | 3.982 |
March 04, 2024 | 3.942 |
March 01, 2024 | 3.945 |
February 29, 2024 | 3.934 |
February 28, 2024 | 3.966 |
February 27, 2024 | 3.984 |
February 26, 2024 | 3.980 |
February 23, 2024 | 4.013 |
February 22, 2024 | 3.971 |
February 21, 2024 | 3.994 |
February 20, 2024 | 3.930 |
February 16, 2024 | 3.905 |
February 15, 2024 | 4.004 |
February 14, 2024 | 3.986 |
February 13, 2024 | 4.013 |
February 12, 2024 | 4.063 |
Date | Value |
---|---|
February 09, 2024 | 4.020 |
February 08, 2024 | 4.027 |
February 07, 2024 | 4.061 |
February 06, 2024 | 4.241 |
February 05, 2024 | 4.186 |
February 02, 2024 | 4.200 |
February 01, 2024 | 4.265 |
January 31, 2024 | 4.271 |
January 30, 2024 | 4.290 |
January 29, 2024 | 4.315 |
January 26, 2024 | 4.340 |
January 25, 2024 | 4.378 |
January 24, 2024 | 4.340 |
January 23, 2024 | 4.337 |
January 22, 2024 | 4.280 |
January 19, 2024 | 4.764 |
January 18, 2024 | 4.715 |
January 17, 2024 | 4.719 |
January 16, 2024 | 4.693 |
January 12, 2024 | 4.714 |
January 11, 2024 | 4.660 |
January 10, 2024 | 4.611 |
January 09, 2024 | 4.696 |
January 08, 2024 | 4.584 |
January 05, 2024 | 4.546 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.446
Minimum
Mar 10 2022
5.431
Maximum
Jul 20 2020
4.260
Average
4.277
Median
Jan 12 2021
Price to Book Value Benchmarks
Amgen Inc | 23.30 |
Johnson & Johnson | 5.490 |
CymaBay Therapeutics Inc | 12.76 |
Arcus Biosciences Inc | 3.387 |
Moderna Inc | 2.875 |
Price to Book Value Related Metrics
PE Ratio | 16.28 |
PS Ratio | 3.398 |
PEG Ratio | 0.6991 |
Price to Free Cash Flow | 12.42 |
Price | 73.26 |
Earnings Yield | 6.14% |
Market Cap | 91.27B |
PEGY Ratio | 0.5939 |
Operating PE Ratio | 10.46 |
Normalized PE Ratio | 13.95 |